
Experience
Apogee Therapeutics Announces Upsized $345.1 Million IPO
July 18, 2023
Cooley advised the underwriters in the upsized $345.1 million initial public offering of Apogee Therapeutics, a biotechnology company.
Related contacts
Related Practices & Industries
CyberGRX Combines With ProcessUnity
July 14, 2023
Cooley advised CyberGRX, a third-party risk management company, on its definitive merger agreement with ProcessUnity.
Related contacts
Related Practices & Industries
ThoughtSpot Acquires Mode Analytics
June 27, 2023
Cooley advised ThoughtSpot, an artificial intelligence-powered analytics company, on its definitive agreement to acquire Mode Analytics for $200 million.
Related contacts
Related Practices & Industries
Veritone Acquires Broadbean
June 5, 2023
Cooley is advising Veritone, an artificial intelligence company, on its acquisition of Broadbean for $52 million.
Related contacts
Related Practices & Industries
ACELYRIN Announces Pricing of Upsized Initial Public Offering
May 15, 2023
Cooley advised Acelyrin, INC., a late-stage biopharmaceutical company, in its $621 million initial public offering, the second-largest biotechnology IPO and largest clinical-stage biotechnology IPO ever.